Anna Cifuentes-Rius, PhD, is responsible for bridging Exopharm’s innovation and commercial teams, helping shape Exopharm’s research and business development strategy. Before joining Exopharm, Dr Cifuentes-Rius was an academic scientist leading a research team towards the development of targeted nanoparticles for drug delivery.

She has worked at world-leading universities, such as the Monash Institute of Pharmaceutical Sciences (Parkville, Australia) and Massachusetts Institute of Technology (MA, US). Dr Cifuentes-Rius’ innovations have resulted in 28 publications, one patent and over AU$1,000,000 in secured funding. She has been awarded several awards in recognition of her emerging leadership, such as the 2020 MIPS Early Career Researcher Award.